Rafeh Naqash, MD(@thenasheffect) 's Twitter Profileg
Rafeh Naqash, MD

@thenasheffect

Asst Prof. @StephensonCC Phase 1 trials #IMmunoOnc and PrecisionMed, #PhyscianNOTProvider @JCOPO_ASCO social media editor #FromKashmir ● #SpaceAndMedicine 👨‍🚀

ID:1040953506520293377

linkhttps://www.google.com/amp/s/www.researchgate.net/profile/Abdul_Rafeh_Naqash2/amp calendar_today15-09-2018 13:20:30

2,8K Tweet

2,1K Takipçi

1,8K Takip Edilen

JCO Precision Oncology(@JCOPO_ASCO) 's Twitter Profile Photo

🎧 In this episode, Rafeh Naqash, MD speaks w/ Jun Gong
about his 2 pubs, 'Phase 2 Study of Erdafitinib in Patients with Tumors with FGFR Amplifications' & 'Phase 2 Study of Erdafitinib in Patients with Tumors with FGFR Mutations or Fusions' ➡️ brnw.ch/21wJCNo

🎧 In this episode, @thenasheffect speaks w/ @jgong15 about his 2 #JCOPO pubs, 'Phase 2 Study of Erdafitinib in Patients with Tumors with FGFR Amplifications' & 'Phase 2 Study of Erdafitinib in Patients with Tumors with FGFR Mutations or Fusions' ➡️ brnw.ch/21wJCNo
account_circle
Yale Cardiology(@YaleCardiology) 's Twitter Profile Photo

'Caring for patients is both humbling and rewarding. You meet patients in their most vulnerable state, and they often trust you with their most valuable assets—their body and their loved ones.' Learn about clinical fellow Sarah Abou Alaiwi, MD, medicine.yale.edu/internal-medic…

account_circle
Rafeh Naqash, MD(@thenasheffect) 's Twitter Profile Photo

‼️Excited to share work led by lab Huntsman Cancer Institute in developing irAE explorer an interactive tool for irAEs now out in irae.tanlab.org Siwen Hu-Lieskovan

academic.oup.com/oncolo/article…

account_circle
Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ(@APassaroMD) 's Twitter Profile Photo

Giants of Cancer Care 2024

Congrats Solange Peters for your outstanding dedication, leadership, and commitment to advancing lung cancer research!

onclive.com/view/giants-of… via @onclive

account_circle
Rafeh Naqash, MD(@thenasheffect) 's Twitter Profile Photo

Looking forward to CoChairing the Developmental Therapeutics -Immunotherapy Orals ASCO with the ⭐️Tian Zhang, MD, MHS.We have a superb line up of speakers and cutting edge IO trails @asco # Dan Olson Ulka Vaishampayan Anthony P Conley Elena Garralda Sandra P D'Angelo, MD and others

Looking forward to CoChairing the Developmental Therapeutics -Immunotherapy Orals @ASCO with the ⭐️@TiansterZhang.We have a superb line up of speakers and cutting edge IO trails @asco #ASCO24 # @DanielOlsonMD @DrVaishampayan @APConley77 @ElenaGarralda @sandrapdangelo and others
account_circle
Journal for ImmunoTherapy of Cancer(@jitcancer) 's Twitter Profile Photo

Meet the Author: Amin H. Nassar (Amin Nassar, MD), a medical oncology fellow from Yale Cancer Center, is co-1st author of “Clinical Outcomes and Safety of Immune Checkpoint Inhibitors in Patients with Solid Tumors and Paraneoplastic Syndromes,” recently published in ! 1/6

Meet the Author: Amin H. Nassar (@AminNassarMD), a medical oncology fellow from @YaleCancer, is co-1st author of “Clinical Outcomes and Safety of Immune Checkpoint Inhibitors in Patients with Solid Tumors and Paraneoplastic Syndromes,” recently published in #JITC! 1/6
account_circle
Lynn M. Schuchter, MD, FASCO(@ASCOPres) 's Twitter Profile Photo

2024 brought 170+ ASCO members representing 48 states—incl. Alaska & Hawaii—plus DC and Puerto Rico. Such an inspiring & energizing week of bold action in our Nation’s capital on behalf of our patients.

Advocate year-round at: asco.org/ACTnetwork

account_circle